Photo from wikipedia
Recently in this journal, Salfinger and Migliori [1] discussed the accessibility of bedaquiline drug susceptibility testing and the analysis of minimum inhibitory concentrations (MICs) for strains of Mycobacterium tuberculosis. As… Click to show full abstract
Recently in this journal, Salfinger and Migliori [1] discussed the accessibility of bedaquiline drug susceptibility testing and the analysis of minimum inhibitory concentrations (MICs) for strains of Mycobacterium tuberculosis. As the recommended treatments for diseases caused by M. avium, and especially M. intracellulare, have high failure rates [2, 3], we measured the MIC of bedaquiline in 20 clinical isolates of these species. Bedaquiline is a potential agent to treat severe or relapsing M. avium-intracellulare complex infections http://ow.ly/n1eR308pERh
Journal Title: European Respiratory Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!